摘要
背景:老年人的认知减退与神经类固醇激素维生素D的不足相关。认知减退的主观认知影响还未能被检测到。这项基于医院的横断面研究为了确定老年病人的主观认知疾病是否与维生素D不足有关。方法:在“认知和亲脂性维生素”(CLIP)研究中99位连贯的白种人和招募病人没有出现晚期认知紊乱(简易精神状态检得分≥20),维生素D摄入不足者依据维生素D量的不足分为2组(血清25-羟基维生素D≥75nmol/L)。采用记忆抱怨调查问卷(MAC-Q;得分0-30;最好)检测主观认知障碍。MAQ-Q得分小于15或者大于30定于为重度认知障碍。年龄、性别、体质指数、教育水平、共患病负荷、功能自主、情绪、血浆甲状旁腺素浓度、钙、促甲状腺素和维生素12及估算肾小球滤过率被作为潜在的混杂因素。结果:与那些血浆25OHD>75nmol/L 的参与者相比,那些维生素D不足者(n=89)的MAC-Q平均得分较低(14.9±2.9与 17.1±1.6, P=0.02),并且MAQ得分小于15的可能性更大(52.8% 与10.0%, P=0.01)。维生素D不足与MAC-Q得分呈负相关(调整β=-2.84, P=0.03),并且与重度认知障碍呈正相关(调整 OR=10.07, P=0.03)结论:在老年病人研究组中,维生素D不足与主观认知障碍相关。
关键词: 认知,认知障碍,痴呆,神经内分泌学,老年人,维生素D
Current Alzheimer Research
Title:Biology of Subjective Cognitive Complaint Amongst Geriatric Patients: Vitamin D Involvement
Volume: 12 Issue: 2
Author(s): Elena De Neree Tot Babberich, Clemence Gourdeau, Simon Pointel, Bruno Lemarchant, Olivier Beauchet and Cedric Annweiler
Affiliation:
关键词: 认知,认知障碍,痴呆,神经内分泌学,老年人,维生素D
摘要: Background: Insufficiency in vitamin D, a neurosteroid hormone, is associated with cognitive decline in older adults. The impact on the subjective perception of cognitive decline has not yet been examined. The objective of this cross-sectional hospital-based study was to determine whether vitamin D insufficiency was associated with subjective cognitive complaint amongst geriatric patients. Methods: Ninety-nine consecutive Caucasian in- and outpatients recruited in the ’Cognition and LIPophilic vitamins’ (CLIP) study, who had no advanced cognitive disorders (ie, Mini-Mental State Examination score≥20) and who took no vitamin D supplements, were categorized into 2 groups based on vitamin D insufficiency (ie, serum 25-hydroxyvitamin D≥75nmol/L). Subjective cognitive complaint was examined using the Memory Complaint Questionnaire (MAC-Q; score 0-30, best). MAC-Q score<15 out of 30 defined severe cognitive complaint. Age, gender, body mass index, education level, comorbidity burden, functional autonomy, mood, and serum concentrations of parathyroid hormone, calcium, thyroid-stimulating hormone and vitamin B12, and estimated glomerular filtration rate were used as potential confounders. Results: Compared to participants with serum 25OHD>75nmol/L, those with vitamin D insufficiency (n=89) had a lower mean MAC-Q score (14.9±2.9 versus 17.1±1.6, P=0.02) and more often a MAC-Q score<15 (52.8% versus 10.0%, P=0.01). Vitamin D insufficiency was inversely associated with the MAC-Q score (adjusted β=-2.84, P=0.03), and positively associated with severe cognitive complaint (adjusted OR=10.07, P=0.03). Conclusion: Vitamin D insufficiency was associated with subjective cognitive complaint in the studied cohort of geriatric patients.
Export Options
About this article
Cite this article as:
Elena De Neree Tot Babberich, Clemence Gourdeau, Simon Pointel, Bruno Lemarchant, Olivier Beauchet and Cedric Annweiler , Biology of Subjective Cognitive Complaint Amongst Geriatric Patients: Vitamin D Involvement, Current Alzheimer Research 2015; 12 (2) . https://dx.doi.org/10.2174/1567205012666150204123504
DOI https://dx.doi.org/10.2174/1567205012666150204123504 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Design, Synthesis and Biological Evaluation of Scutellarein Derivatives as Potential Anti-Alzheimers Disease Candidates Based on Metabolic Mechanism
Letters in Drug Design & Discovery A New Glucocorticoid Hypothesis of Brain Aging: Implications for Alzheimers Disease
Current Alzheimer Research “Micromanaging” Glioblastoma Multiforme: The Potential of MicroRNAs, Circular RNAs, and the Hippo Pathway as Novel Treatment Strategies
Current Neurovascular Research Chaperone-like Activity of alpha-Crystallin and Other Small Heat Shock Proteins
Current Protein & Peptide Science Anthocyanins: Plant Pigments, Food Ingredients or Therapeutic Agents for the CNS? A Mini-Review Focused on Clinical Trials
Current Pharmaceutical Design Statins And Stroke
Current Medicinal Chemistry Adipose Tissue and Bone Marrow as Sources for Cell-based Therapeutic Angiogenesis in Ischemic Tissues: Biological Foundation and Clinical Prospects for Age-related Vascular Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Racial Differences in Gray Matter Integrity by Diffusion Tensor in Black and White Octogenarians
Current Alzheimer Research Therapeutic Targeting of the Endoplasmic Reticulum in Alzheimers Disease
Current Alzheimer Research Current and Potential Use of Citrus Essential Oils
Current Organic Chemistry Seeing Early Signs of Alzheimer's Disease Through the Lens of the Eye
Current Alzheimer Research The Effects of Gender and CYP46 and Apo E Polymorphism on 24S-Hydroxycholesterol Levels in Alzheimers Patients Treated with Statins
Current Alzheimer Research Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer’s Disease
Mini-Reviews in Medicinal Chemistry Peptidase Inhibitors as a Possible Therapeutic Strategy for Chagas Disease
Current Enzyme Inhibition Systemic Inflammation, Infection, ApoE Alleles, and Alzheimer Disease: A Position Paper
Current Alzheimer Research Potential Benefits and Limits of Psychopharmacological Therapies in Pervasive Developmental Disorders
Current Clinical Pharmacology Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Neural Stem Cell Niches in Health and Diseases
Current Pharmaceutical Design Does Non-Invasive Brain Stimulation Improve Cognition in Major Depressive Disorder? A Systematic Review
CNS & Neurological Disorders - Drug Targets Meta-Analysis of the Effectiveness and Safety of Prophylactic Use of Nimodipine in Patients with an Aneurysmal Subarachnoid Haemorrhage
CNS & Neurological Disorders - Drug Targets